COZZI, VALERIA
 Distribuzione geografica
Continente #
EU - Europa 2.073
NA - Nord America 1.608
AS - Asia 577
SA - Sud America 27
Continente sconosciuto - Info sul continente non disponibili 17
AF - Africa 15
OC - Oceania 3
Totale 4.320
Nazione #
US - Stati Uniti d'America 1.510
GB - Regno Unito 935
IT - Italia 335
CN - Cina 325
SE - Svezia 235
DE - Germania 147
CA - Canada 98
UA - Ucraina 90
IN - India 81
TR - Turchia 59
BE - Belgio 58
FR - Francia 57
IE - Irlanda 54
KR - Corea 54
EU - Europa 47
RU - Federazione Russa 42
FI - Finlandia 36
NL - Olanda 32
CO - Colombia 18
HK - Hong Kong 16
DK - Danimarca 13
GR - Grecia 11
VN - Vietnam 10
PL - Polonia 9
CH - Svizzera 8
ID - Indonesia 8
ZA - Sudafrica 8
SG - Singapore 7
JP - Giappone 6
CL - Cile 4
EC - Ecuador 4
RO - Romania 4
AU - Australia 3
MY - Malesia 3
SC - Seychelles 3
ES - Italia 2
LK - Sri Lanka 2
NG - Nigeria 2
PT - Portogallo 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AT - Austria 1
BR - Brasile 1
CZ - Repubblica Ceca 1
EE - Estonia 1
ET - Etiopia 1
IR - Iran 1
ML - Mali 1
PK - Pakistan 1
TW - Taiwan 1
Totale 4.351
Città #
Southend 844
Chandler 191
Milan 152
Ann Arbor 124
Wilmington 106
Seattle 103
Dearborn 88
Princeton 83
Ashburn 76
Beijing 75
Jacksonville 72
Brussels 55
Dublin 54
New York 48
Ottawa 48
Toronto 46
Fairfield 45
Nanjing 43
Phoenix 43
Woodbridge 38
Houston 37
Des Moines 36
Mountain View 33
Serra 33
Redmond 31
Shenyang 26
Bengaluru 25
Boardman 22
Jinan 22
Somerville 22
Andover 21
Sakarya 20
Berlin 16
Bogotá 16
Nanchang 16
Boise 15
Cambridge 14
Redwood City 12
Frankfurt am Main 11
Haikou 11
Istanbul 11
Shanghai 10
Taizhou 10
Changsha 9
Medford 9
Ningbo 9
Rome 9
Seoul 9
Zhengzhou 9
Hebei 8
Paris 8
San Diego 8
Falls Church 7
Helsinki 7
Kunming 7
Lowell 7
Warsaw 7
Hanover 6
Hefei 6
Hong Kong 6
Johannesburg 6
Kwai Chung 6
Pskov 6
Bethesda 5
Dong Ket 5
Guangzhou 5
Jiaxing 5
Rho 5
Tianjin 5
Turin 5
Athens 4
Bitonto 4
Fuzhou 4
Hangzhou 4
Palaiseau 4
Quito 4
Amsterdam 3
Atlanta 3
Auburn Hills 3
Beaufays 3
Detroit 3
Kuala Lumpur 3
London 3
Mahé 3
Melegnano 3
Saint Petersburg 3
Scranton 3
Boston 2
Buffalo 2
Cassano Magnago 2
Central District 2
Centro 2
Columbus 2
Decatur 2
Exton 2
Fremont 2
Grafing 2
Gussago 2
Kiez 2
Lagos 2
Totale 3.071
Nome #
Metabolic and kidney disorders correlate with high atazanavir concentrations in HIV-infected patients : is it time to revise atazanavir dosages? 212
Studio dell’espressione genica in biopsie sottocutanee di pazienti obesi affetti da sindrome metabolica 198
Ruolo dell’ossido nitrico nella mitocondriogenesi e nella modulazione dell’espressione genica correlata al differenziamento e all’attività delle cellule adipose 182
Phenotype and metabolic characterization of eNos-/- mice : a new model of metabolic syndrome? 180
Morphofunctional characterization of the mitochondria in tissues from different animal models of obesity 180
Impact of Therapeutic Drug Monitoring of Antiretroviral Drugs in Routine Clinical Management of People Living with HIV: A Narrative Review 166
Combined isosorbide dinitrate and ibuprofen as a novel therapy for muscular dystrophies : evidence from Phase I studies in healthy volunteers 163
Ruolo dell’ossido nitrico e della mitocondriogenesi nei fenomeni mediati dalla restrizione calorica 154
La sensibilità al processo di morte cellulare negli adipociti bianchi e bruni 146
Mitochondrial biogenesis by NO yields functionally active mitochondria in mammals 144
Clinical and genetic determinants of nevirapine plasma trough concentration 143
Calorie restriction promotes mitochondrial biogenesis by inducing the expression of eNOS 141
Mitochondrial biogenesis in mammals : the role of endogenous nitric oxide 138
Coinvolgimento del sistema dell’ossido nitrico nel mediare gli effetti pleiotropici della rosuvastatina 137
White adipocytes are less prone to apoptotic stimuli than brown adipocytes in rodent 135
Nitric oxide modulates the expression of genes involved in fat cells differentiation and function 129
Co-administration of raltegravir reduces daily darunavir exposure in HIV-1 infected patients 126
Amino acids and mitochondrial biogenesis 125
Limited sampling strategies for the estimation of atazanavir daily exposure in HIV-infected patients 125
TNF-alpha downregulates eNOS expression and mitochondrial biogenesis in fat and muscle of obese rodents 123
NO e biogenesi mitocondriale in tessuti di diversi modelli animali di obesità 118
Limited Sampling Strategies for the Estimation of Raltegravir Daily Exposure in HIV-Infected Patients 118
PTX3 as a potential endothelial dysfunction biomarker for severity of preeclampsia and IUGR 103
Linezolid plasma concentrations and occurrence of drug-related haematological toxicity in patients with Gram-positive infections 97
High isavuconazole plasma levels in a patient with possible invasive pulmonary aspergillosis and cirrhosis 94
Is it time to revise antiretrovirals dosing? : a pharmacokinetic viewpoint 88
Determination of linezolid in human plasma by high-performance liquid chromatography with ultraviolet detection 87
Development and validation of a chromatographic ultraviolet method for the simultaneous quantification of dolutegravir and rilpivirine in human plasma 87
Comparison of the ARK Immunoassay With High-Performance Liquid Chromatography With Ultraviolet Detection for Therapeutic Drug Monitoring of Linezolid 83
Assessment of Antiepileptic Drug Concentrations in HIV-Infected versus HIV-Negative Patients: A Retrospective Analysis 83
Is it time to revise linezolid doses in peritoneal dialysis patients? A case series 82
Development and Validation of a Chromatographic-UV Method for the Quantification of Isavuconazole in Human Plasma Samples 81
Comparison of the In Vivo Pharmacokinetics and In Vitro Dissolution of Raltegravir in HIV Patients Receiving the Drug by Swallowing or by Chewing 74
Comparison of the QMS® analyzer with HPLC-UV for the quantification of lamotrigine concentrations in human plasma samples 70
Effects of ritonavir and cobicistat on dolutegravir exposure : when the booster can make the difference 67
Dolutegravir plasma concentrations according to companion antiretroviral drug: unwanted drug interaction or desirable boosting effect? 66
Pharmacogenetics-based optimisation of atazanavir treatment : potential role of new genetic predictors 58
Therapeutic drug management of linezolid : a missed opportunity for clinicians? 56
Supra-therapeutic Linezolid Trough Concentrations in Elderly Patients : a Call for Action? 56
Totale 4.615
Categoria #
all - tutte 8.418
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.418


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019261 0 0 0 0 0 45 56 8 41 36 37 38
2019/2020656 77 11 25 37 44 92 78 33 114 82 39 24
2020/2021562 72 43 44 5 56 31 45 43 54 39 102 28
2021/2022519 45 19 15 13 35 26 48 11 115 57 37 98
2022/2023700 85 95 69 61 73 134 8 36 90 7 33 9
2023/2024249 12 34 25 27 108 43 0 0 0 0 0 0
Totale 4.615